Svas Biosana S.p.A. (BIT:SVS)
Italy · Delayed Price · Currency is EUR 8.38
0.00 (0.00%)
At close: Aug 14, 2026
Svas Biosana Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 44 | 43 | 38 | 43 | 55 | 87 | |
Market Cap Growth | 0.21% | 10.91% | -11.25% | -20.87% | -37.13% | - |
Enterprise Value | 83 | 87 | 69 | 72 | 84 | 129 |
Last Close Price | 8.38 | 7.82 | 6.73 | 7.30 | 8.94 | 14.14 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 6.48 | 6.28 | 6.52 | 8.43 | 15.29 | 27.47 |
Forward PE | 6.60 | 5.59 | 5.92 | 8.56 | 10.60 | - |
PS Ratio | 0.31 | 0.30 | 0.31 | 0.36 | 0.55 | 1.06 |
PB Ratio | 0.65 | 0.63 | 0.61 | 0.73 | 1.00 | 1.70 |
P/TBV Ratio | 0.88 | 0.86 | 0.75 | 0.89 | 1.22 | 2.07 |
P/FCF Ratio | 16.04 | 15.58 | 26.90 | 83.07 | 28.74 | - |
P/OCF Ratio | 6.82 | 6.62 | 7.46 | 10.06 | 11.17 | 34.24 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.59 | 0.62 | 0.56 | 0.60 | 0.84 | 1.57 |
EV/EBITDA Ratio | 4.71 | 4.97 | 4.56 | 5.33 | 7.55 | 12.49 |
EV/EBIT Ratio | 6.77 | 7.15 | 7.01 | 8.45 | 13.31 | 22.30 |
EV/FCF Ratio | 30.36 | 32.04 | 48.22 | 139.22 | 44.04 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.13 | 1.13 | 1.05 | 1.14 | 1.01 | 1.07 |
Debt / EBITDA Ratio | 4.35 | 4.35 | 4.38 | 4.94 | 4.99 | 5.27 |
Debt / FCF Ratio | 28.00 | 28.00 | 46.31 | 129.22 | 29.10 | - |
Net Debt / Equity Ratio | 0.58 | 0.58 | 0.46 | 0.46 | 0.47 | 0.46 |
Net Debt / EBITDA Ratio | 2.21 | 2.21 | 1.90 | 2.00 | 2.32 | 2.26 |
Net Debt / FCF Ratio | 14.27 | 14.27 | 20.06 | 52.27 | 13.55 | -278.79 |
Asset Turnover | 0.81 | 0.81 | 0.74 | 0.78 | 0.71 | 0.67 |
Inventory Turnover | 2.75 | 2.75 | 2.64 | 2.86 | 2.58 | 2.35 |
Quick Ratio | 1.27 | 1.27 | 1.42 | 1.38 | 1.28 | 1.34 |
Current Ratio | 1.82 | 1.82 | 1.98 | 1.89 | 1.81 | 1.86 |
Return on Equity (ROE) | 10.38% | 10.38% | 9.65% | 9.03% | 6.77% | 8.03% |
Return on Assets (ROA) | 4.37% | 4.37% | 3.70% | 3.43% | 2.78% | 2.96% |
Return on Invested Capital (ROIC) | 8.51% | 9.16% | 8.10% | 7.76% | 6.24% | 6.41% |
Return on Capital Employed (ROCE) | 11.00% | 11.00% | 9.50% | 8.50% | 7.10% | 6.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 15.47% | 15.93% | 15.33% | 11.86% | 6.54% | 3.64% |
FCF Yield | 6.24% | 6.42% | 3.72% | 1.20% | 3.48% | -0.10% |
Dividend Yield | 2.39% | 2.56% | 3.71% | 4.11% | - | - |
Payout Ratio | 19.56% | 19.56% | 27.24% | - | - | - |
Buyback Yield / Dilution | 1.74% | 1.74% | - | - | - | - |
Total Shareholder Return | 4.13% | 4.30% | 3.71% | 4.11% | - | - |